ArticleBlood advances2021

Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.

Reid W Merryman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.